紫杉醇耐药的研究进展.pdf

现代肿瘤医学2014年8月第22卷第8期 MODERN ONCOLOGY,Aug-2014,VOL.22,NO.08
cetaxel(T) combined with eisplatin(C) and 5-fluo
orouracil and leucovorin(PFL ) in patients(pts )with advanced
to CF in patients with metastastic gastric adenocarcinoma(MGC)
esophago-gastric(EG) adenocarcinoma [JJ. J Clin Oncol
C]. J Clin One Proc Am Soc Soc Clin Oncol, 2005, 2
pp
I 15) Cunningham D, Rao S, Starling N, et al. Randomised multicentre
rgensen JT. Targeted HER-2 treatment in advanced gastric
phase II study comparing capecitabine with fluorouracil and ox
ancer [J]. Oncology, 2010, 78: 26-2
aliplatin with cisplatin in patients with advanced oesophagogastric 24 Wainberg ZA, Anghel A, Desai AJ, et al. Lapatinib, a dual EGFR
(0G )cancer. The REAL 2 trial [J]. Proc Am Soc Clin Oncol
and HER-2 kinase inhibitor, selectively inhibits HER-2 -at
2006,24(18s):4017
plified human gastric cancer cells and is synergistic with trastu
16] Koizumi W, Narahara H, Ilara T, et al. S-1 plus cisplatin versus
zumab in vitro and in vivo.]]. Clin Cancer Res, 2010, 16: 1509
S-1 alone for first -line treatment of advanced gastric cancer
(SPIRITS trial ): a phase Il trial[ J]. lancet Oncol, 2008, 9: 215 [25] Shah MA, Ramanathan RK Multicenter phase I study of irinote
can, cisplatin, and bevacizumab in patients with metastatic gastric
[17: Hegewisch
rovic
or gastroesophageal junction adenocarcinoma J]. J Clin Oncol
hyperthermia (41.8 degrees C)combined with bimonthly oxali
006,24(33):5201-5206
platin, high-dose leucovorin and 5 -fluorouracil 48-hour con- [ 26J Kang Y, Ohtsu A, Van Cutsem E, et al. AVAGAST: A randomized
tinuous infusion in pretreated metastatic colorectal cancer:a phase
double-blind placebo-controlled, phase Il study of first-line
II study[J. Ann Oncol,2002,13(8):119-1204.
capecitabine and cisplatin plus bevacizumab or placebo in patients
18」郑鸿,李勇,房定珠,等.热疔联合 FOLFOX方案治疗21例晚
with advanced gastric cancer(AGC)[J]. J Clin Oncol, 2010, 28
期胃癌[J].中国癌症杂志,2006,16(7):581-583
(18):18
19 Pinto C Phase I study of cetuximab in combination with FOLFIRI 27] Yu J, Lung WK, Ee MP, et al. Increased expression of survivin
in patients with untreated advanced gastric or gastroesophageal
in gastric cancer patients and in first degree relatives LJ]. Br J
junction adenocarcinoma(FOLCETUX study )[J]. Ann Oncol
Cancer,2002,87(1):91-97
2007,18(3):510-517
[28 Ooi VE, Liu F Immunomodulation and anti-cancer activity of
[20] Abad A, New drugs in the treatment of gastric tumors [J]. Clin
polysaccharide-protein complexes [J ]. Curr Med Chem, 2000, 7
ran
261
7):715-729
21 Han SW, Oh DY, Im SA, et al. Phase II study and biomarker anal
29] Baker-lepain JC, Reed RC, Nicchitta CV. ISO: a critical evalua
ysis of cetuximab combined with modified FOLFOX6 in advanced
tion of the role of peptides in heat shock/chaperone proteinmediat-
gastric cancer [J]. Br J Cancer, 2009, 100(2): 298-304
ed tumor rejection [JJ. Curr Opin Immunol, 2003, 15(1): 89
22] Trarbach T, Schleucher N, Weber D, ct al. Phase I study of hi
94
(编校:闫沛
manized anti-epidermal growth factor receptor(EGFR)antibod
紫杉醇耐药的硏究进展
沈丽平,范理宏
Research progress of neoplasms resistance
ng
School of Medicine, Schw niversity ag Suh 215123, hi Deparment of ncology, Shan h P